1207745-47-8

Basic information

• Product Name: methyl 5-[5-[(5-chloropyridin-2-yl)thio]-2-(4-fluorophenyl)-1,3-oxazol-4-yl]pyrazine-2-carboxylate
• Synonyms: methyl 5-[5-[(5-chloropyridin-2-yl)thio]-2-(4-fluorophenyl)-1,3-oxazol-4-yl]pyrazine-2-carboxylate
• CAS NO: 1207745-47-8
• Molecular Weight: 442.858
• Mol File: 1207745-47-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: methyl 5-[5-[(5-chloropyridin-2-yl)thio]-2-(4-fluorophenyl)-1,3-oxazol-4-yl]pyrazine-2-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 5-[5-[(5-chloropyridin-2-yl)thio]-2-(4-fluorophenyl)-1,3-oxazol-4-yl]pyrazine-2-carboxylate(1207745-47-8)
• EPA Substance Registry System: methyl 5-[5-[(5-chloropyridin-2-yl)thio]-2-(4-fluorophenyl)-1,3-oxazol-4-yl]pyrazine-2-carboxylate(1207745-47-8)

Safety Data

• Hazardous Substances Data: 1207745-47-8(Hazardous Substances Data)

Upstream product

• 1262656-82-5 2-pyrazinecarboxylic acid, 5-[2-(4-fluorophenyl)-5-iodo-4-oxazolyl]-methyl ester 
• 40771-41-3 2-mercapto-5-chloro-pyridine 

Downstream Products

• 1207745-49-0 2-{5-[5-[(5-chloropyridin-2-yl)thio]-2-(4-fluorophenyl)-1,3-oxazol-4-yl]pyrazin-2-yl}propan-2-ol 

Relevant articles and documents

OXAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH

The present invention is directed to certain oxazole derivatives which are useful as inhibitors of Fatty Acid Amide Hydrolase (FAAH). The invention is also concerned with pharmaceutical formulations comprising these compounds as active ingredients and the use of the compounds and their formulations in the treatment of certain disorders, including osteoarthritis, rheumatoid arthritis, diabetic neuropathy, postherpetic neuralgia, skeletomuscular pain, and fibromyalgia, as well as acute pain, migraine, sleep disorder, Alzheimer Disease, and Parkinson's Disease.